[Multiple sclerosis; current developments in the pathogenesis and treatment].
D000911:Antibodies, Monoclonal / Q000276:immunology; D003524:Cyclosporins / Q000627:therapeutic use; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000276:immunology; D009103:Multiple Sclerosis / Q000276:immunology* / Q000628:therapy; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II; D007372:Interferons
Multipele sclerose; nieuwe ontwikkelingen op het gebied van pathogenese en behandeling.